Use of sugammadex to reverse alfaxalone anesthesia in rats
Veterinary Anaesthesia and Analgesia · 2026
DOI: 10.1016/j.vaa.2025.11.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Anaesthesia and Analgesia, 2026. Verfasst von Benjamin Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of California, Davis, Davis, CA, USA. Hauptthemen laut MEDLINE: Pregnanediones, Sugammadex. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: School of Veterinary Medicine, University of California, Davis, University of California Davis Center for Companion Animal Health.
Abstract (Originalsprache)
OBJECTIVE: To test whether sugammadex, a reversal agent for steroid neuromuscular blocking drugs, could encapsulate the neurosteroid alfaxalone and accelerate anesthetic recovery. STUDY DESIGN: Prospective, blinded, randomized, crossover study. ANIMALS: Thirty-six male and female adult Sprague-Dawley rats. METHODS: Six male and six female adult Sprague-Dawley rats were intravenously administered 3 mg kg-1 alfaxalone followed 1 minute later by either 0.9% saline or 96 mg kg-1 sugammadex, with a 1 week washout period between repeat anesthetics. A separate cohort of 12 rats was studied using an identical experimental design, but with a 6 mg kg-1 alfaxalone dose. A third cohort of 12 rats was given 12 mg kg-1 alfaxalone followed by saline or sugammadex (96 mg kg-1 dose or 192 mg kg-1 dose) using a Latin-square crossover design with 1 week between repeated anesthetics. Physiological and behavioral recovery responses were assessed every minute by an observer who was blinded to treatment. Data were analyzed using repeated-measures ANOVA with Šidák post hoc comparisons (p < 0.05). RESULTS: Compared with saline controls, sugammadex shortened recovery times by 40-60% following anesthesia induction with the 3 or 6 mg kg-1 alfaxalone doses (p ≤ 0.002). For the 12 mg kg-1 alfaxalone dose, the low and the high sugammadex doses shortened recovery times by 25-50% and 50-61%, respectively, compared with saline controls, with all differences being significant (p ≤ 0.003) except for movement following tail clamp (p = 0.112-0.419). This higher sugammadex dose also shortened the same significant recovery end points compared with the lower sugammadex dose (p = 0.007-0.050). At higher alfaxalone doses, female rats exhibited significantly slower recoveries than male rats. CONCLUSIONS AND CLINICAL RELEVANCE: Sugammadex can be used to reverse anesthetic effects from alfaxalone in rats. Recovery speed from alfaxalone anesthesia is dependent on sugammadex dose and sex.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of California, Davis, Davis, CA, USA.
- University of California, Davis, Davis, CA, USA. Electronic address: rjbrosnan@ucdavis.edu.
- University of California, Davis, Davis, CA, USA; Departamento de Cirurgia Veterinária e Reprodução Animal, FMVZ-Universidade Estadual Paulista, Botucatu, Brazil.
Förderung
- School of Veterinary Medicine, University of California, Davis
- University of California Davis Center for Companion Animal Health
Zitieren
APA
Chen, B., Brosnan, R. J., & Aguiar, A. J. (2026). Use of sugammadex to reverse alfaxalone anesthesia in rats. Veterinary Anaesthesia and Analgesia. https://doi.org/10.1016/j.vaa.2025.11.004
Vancouver
Chen B, Brosnan RJ, Aguiar AJ. Use of sugammadex to reverse alfaxalone anesthesia in rats. Veterinary Anaesthesia and Analgesia. 2026. doi:10.1016/j.vaa.2025.11.004
BibTeX
@article{Chen2026,
author = {Chen, Benjamin and Brosnan, Robert J and Aguiar, Antonio Ja},
title = {Use of sugammadex to reverse alfaxalone anesthesia in rats},
journal = {Veterinary Anaesthesia and Analgesia},
year = {2026},
doi = {10.1016/j.vaa.2025.11.004}
}
EUVIMED